Treatment with inhibitors of angiogenesis in advanced hepatocellular carcinoma: a new tool in our hands or simply a hope?

Cipriani, G; Mazzanti, R

Cipriani, G; Mazzanti, R.

Affiliation

Cipriani G; Department of Internal Medicine, Postgraduate School in Oncology, MCIDNENT, University of Florence, Viale Morgagni 85, 50134 Florence, Italy.

Dig Liver Dis ; 37(4): 230-1, 2005 Apr.

Article in En | MEDLINE | ID: mdl-15788205

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Carcinoma, Hepatocellular/drug therapy; Liver Neoplasms/drug therapy; Antineoplastic Agents, Hormonal/administration & dosage; Antineoplastic Agents, Hormonal/therapeutic use; Carcinoma, Hepatocellular/blood supply; Carcinoma, Hepatocellular/metabolism; Fibroblast Growth Factor 2/metabolism; Hepatocyte Growth Factor/metabolism; Humans; Interleukin-2/administration & dosage; Interleukin-2/therapeutic use; Liver Neoplasms/blood supply; Liver Neoplasms/metabolism; Megestrol/administration & dosage; Megestrol/therapeutic use; Thalidomide/administration & dosage; Thalidomide/therapeutic use; Treatment Outcome; Vascular Endothelial Growth Factor A/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Angiogenesis Inhibitors / Liver Neoplasms Limits: Humans Language: En Journal: Dig Liver Dis Journal subject: GASTROENTEROLOGIA Year: 2005 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links